PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 22 filers reported holding PSYCHEMEDICS CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 41,501 | $189,243 | 0.08% |
| SANTA MONICA PARTNERS LP | 20,000 | $91 | 0.07% |
| Cannell Capital | 74,794 | $341,061 | 0.07% |
| RBF Capital, LLC | 144,231 | $657,693 | 0.04% |
| CRAWFORD INVESTMENT COUNSEL INC | 242,113 | $1,104,034 | 0.02% |
| Ancora Advisors LLC | 78,373 | $357,380 | 0.01% |
| WEDBUSH SECURITIES INC | 34,157 | $156 | 0.01% |
| Renaissance Technologies | 277,963 | $1,268 | 0.00% |
| CALDWELL SUTTER CAPITAL, INC. | 577 | $2,631 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 35,206 | $160,539 | 0.00% |
| NORTHERN TRUST CORP | 18,617 | $84,894 | 0.00% |
| STATE STREET CORP | 16,162 | $73,699 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $153 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 56,155 | $256,067 | 0.00% |
| MORGAN STANLEY | 16,542 | $75,432 | 0.00% |
| FMR LLC | 100 | $456 | 0.00% |
| UBS Group AG | 47 | $214 | 0.00% |
| Tower Research Capital LLC (TRC) | 876 | $3,995 | 0.00% |
| BlackRock Inc. | 77,780 | $354,676 | 0.00% |
| VANGUARD GROUP INC | 247,438 | $1,128,317 | 0.00% |
External links
This page lists PSYCHEMEDICS CORP's shareholders in Q2 2023. To view PSYCHEMEDICS CORP's shareholder history, click here.